Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ABEO
#3373
Abeona Therapeutics Inc. Common Stock
5.1
9
USD
+2.57%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.57%
Changement Mensuel
+9.03%
Evolution sur 6 mois
-2.99%
Changement Annuel
+4.64%
Clôture Précédente
5.0
6
Open
5.1
9
Bid
Ask
Low
5.1
9
High
5.1
9
Volume
44
Marchés
Actions des Marchés US
Soins de Santé
ABEO
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
3.95 M
5.9 M
17.71 M
27.36 M
48.53 M
57.05 M
—
Valuation ratios
Enterprise value
144.26 M
16.73 M
36.43 M
146.78 M
265.94 M
242.25 M
859.39 M
Price to earnings ratio
—
—
-0.52
-2.19
-3.59
5.22
4.72
Price to sales ratio
—
—
15.9
33.78
—
59.89
—
Price to cash flow ratio
—
—
-0.52
-3.19
-4.08
-4.57
-16.29
Price to book ratio
—
—
0.84
7.97
5.19
2.19
5.07
Enterprise value to EBITDA ratio
-1.97
-0.3
-0.76
-3.27
-4.25
-2.7
-11.02
Profitability ratios
Return on assets %
-0.56
-1.07
-0.62
-0.85
-0.59
0.32
0.21
Return on equity %
-0.82
-1.65
-1.48
-3.65
-1.45
0.45
0.22
Return on invested capital %
-313.61
-607.99
-925.94
-1 399.91
-1 787.67
-1 670.79
-1 161.91
Gross margin %
100
100
100
100
—
73.68
—
Operating margin %
-814.2
-2 994.53
-3 600.78
-1 346.71
—
-1 536.91
—
EBITDA margin %
-768.34
-2 886.2
-3 382.04
-1 281.34
—
-1 493.11
—
Net margin %
-842.34
-2 831.2
-2 807.36
-1 548.23
—
1 223.08
—
Liquidity ratios
Quick ratio
—
—
—
—
—
6.74
—
Current ratio
2.33
3.33
6.83
4.15
6.08
6.93
28.3
Inventory turnover
—
—
—
—
—
0.56
—
Asset turnover
0.05
0.03
0.02
0.05
0
0.04
0.03
Solvency ratios
Debt to assets ratio
0.01
0
—
0.16
0.17
0.09
0.45
Debt to equity ratio
0.02
0
—
0.67
0.43
0.13
0.83
Long term debt to total assets ratio
0.01
0
—
0.07
0.12
0.04
0.25
Long term debt to total equity ratio
0.02
0
—
0.31
0.3
0.05
0.47
Per share metrics
Operating cash flow per share
—
—
-5.53
-1.73
-1.36
-1.15
-1.31
EBIT per share
—
—
-6.48
-2.2
-1.56
-1.35
-1.53
EBITDA per share
—
—
-6.08
-2.1
-1.52
-1.31
-1.48
Total debt per share
—
—
—
0.47
0.46
0.3
1.35
Cash per share
—
—
6.68
2.46
2.39
2.89
11.79
Net current asset value per share
—
—
6.75
2.61
2.46
3.1
12.34
Tangible book value per share
—
—
3.23
0.69
1.07
2.41
8.85
Working capital per share
—
—
5.76
1.98
2.05
2.65
10.6
Book value per share
—
—
3.4
0.69
1.07
2.41
8.85
Nouvelles
Abeona Therapeutics nomme Keith Goldan à son conseil d’administration
Le PDG d’Abeona Therapeutics Seshadri Vishwas vend pour 131.000$
Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point (NASDAQ:ABEO)
Oppenheimer réitère sa recommandation Surperformance sur Abeona Therapeutics
Stifel abaisse l’objectif de cours d’Abeona Therapeutics sur le calendrier des ventes
Le directeur financier d’Abeona Therapeutics, Vazzano, vend pour 3.700$ d’actions
Abeona Therapeutics CFO Vazzano sells $3.7k in stock
Oppenheimer relève l’objectif de cours d’Abeona Therapeutics suite aux progrès du lancement
Oppenheimer raises Abeona Therapeutics price target on launch progress
Abeona annonce des progrès dans le lancement de la thérapie génique ZEVASKYN
Abeona reports progress in ZEVASKYN gene therapy launch
3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts - TipRanks.com